Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$41.33 - $74.26 $157,839 - $283,598
3,819 New
3,819 $160,000
Q2 2021

Aug 11, 2021

SELL
$93.66 - $139.27 $104,992 - $156,121
-1,121 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$116.57 - $155.01 $345,979 - $460,069
-2,968 Reduced 72.58%
1,121 $148,000
Q4 2020

Feb 11, 2021

BUY
$99.61 - $142.12 $407,305 - $581,128
4,089 New
4,089 $542,000
Q1 2018

Apr 12, 2018

SELL
$39.82 - $57.53 $6,092 - $8,802
-153 Closed
0 $0
Q3 2017

Oct 13, 2017

BUY
$37.05 - $47.12 $5,668 - $7,209
153
153 $7,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.